Inventor · disambiguated record
Robert F. Bruns, Jr.
Also filed as: BRUNS JR ROBERT F · BRUNS JR ROBERT FREDERICK · BRUNS ROBERT F · BRUNS ROBERT F JR
28 granted patents·6 pending applications·587 citations·filing 1983–2010
97Inventor score
Files withLILLY CO ELI15WARNER LAMBERT CO9AZEVAN PHARMACEUTICALS INC4KING PHARMACEUTICALS INC2UNIV JOHNS HOPKINS2
Top patents by PatentIndex Score
34 records- 0195US4593095AXanthine derivativesUNIV JOHNS HOPKINS·Filed 1983·Granted Jun 3, 1986·68 cites·5 claims
- 0293US4769377AAdenosine receptor antagonistsUNIV JOHNS HOPKINS·Filed 1986·Granted Sep 6, 1988·44 cites·3 claims
- 0393US4755517ADerivatives of xanthine, pharmaceutical compositions and methods of use thereforWARNER LAMBERT CO·Filed 1986·Granted Jul 5, 1988·39 cites·9 claims
- 0492US7268125B2β-lactamyl vasopressin V1a antagonistsAZEVAN PHARMACEUTICALS INC·Filed 2006·Granted Sep 11, 2007·19 cites·70 claims
- 0589US5567714AMethods of treating obesity by inhibiting physiological conditions associated with an excess of neuropeptide YLILLY CO ELI·Filed 1995·Granted Oct 22, 1996·60 cites·4 claims
- 0687US7119083B2β-Lactamyl vasopressin V1a AntagonistsAZEVAN PHARMACEUTICALS INC·Filed 2002·Granted Oct 10, 2006·22 cites·70 claims
- 0786US6204260B1Non-peptidyl vasopressin V1a antagonistsLILLY CO ELI·Filed 1997·Granted Mar 20, 2001·62 cites·12 claims
- 0884US5759865ACombinatorial process for synthesizing azetidinone analogsLILLY CO ELI·Filed 1995·Granted Jun 2, 1998·40 cites·13 claims
- 0982US6610680B1Non-peptidyl vasopressin V1A antagonistsLILLY CO ELI·Filed 2002·Granted Aug 26, 2003·14 cites·7 claims
- 1076US6245761B1Indolyl neuropeptide Y receptor antagonistsLILLY CO ELI·Filed 1996·Granted Jun 12, 2001·21 cites·33 claims
- 1176US5504094AUse of bengothiophenls to treat pain due to an excess of neuropeptide yLILLY CO ELI·Filed 1995·Granted Apr 2, 1996·26 cites·3 claims
- 1275US4761424AEnolamides, pharmaceutical compositions and methods for treating inflammationWARNER LAMBERT CO·Filed 1985·Granted Aug 2, 1988·21 cites·20 claims
- 1374US5576337AMethod of treating anxiety by inhibiting physiological conditions associated with an excess of neuropeptide YLILLY CO ELI·Filed 1995·Granted Nov 19, 1996·23 cites·4 claims
- 1470US6255494B1Benzimidzolyl neuropeptide Y receptor antagonistsLILLY CO ELI·Filed 1997·Granted Jul 3, 2001·33 cites·10 claims
- 1565US2008090797A1{Beta}-Lactamyl vasopression V1a antagonists and methods of useAZEVAN PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 1664US5491140ANaphthyl tachykinin receptor antagonists to treat physiological conditionsLILLY CO ELI·Filed 1994·Granted Feb 13, 1996·29 cites·18 claims
- 1761US2008033165A1[Beta]-Lactamyl Vasopressin V1a Antagonists and Methods of UseKOPPEL GARY A·Filed 2007·Application pending·0 cites
- 1859US5663192AHeterocyclic neuropeptide Y receptor antagonistsLILLY CO ELI·Filed 1994·Granted Sep 2, 1997·23 cites·23 claims
- 1957US5567715AMethods of treating depression by inhibiting physiological conditions associated with an excess of neuropeptide YLILLY CO ELI·Filed 1995·Granted Oct 22, 1996·9 cites·4 claims
- 2056US4705758AAdenosine receptor assay and kitWARNER LAMBERT CO·Filed 1984·Granted Nov 10, 1987·14 cites·12 claims
- 2155US2011059935A1Beta-LACTAMYL VASOPRESSIN V1a ANTAGONISTSAZEVAN PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 2251US2002007071A1Benzimidzolyl neuropeptide Y receptor antagonistsFiled 2000·Application pending·0 cites
- 2350US4868200ANovel enolamides, pharmaceutical compositions and methods of use thereof for activity as modulators of the arachidonic acid cascadeWARNER LAMBERT CO·Filed 1988·Granted Sep 19, 1989·3 cites·16 claims
- 2449US2004005354A1Oral trimethobenzamide formulations and methodsKING PHARMACEUTICALS INC·Filed 2003·Application pending·0 cites
- 2548US6562862B1Methods of inhibiting physiological conditions associated with an excess of neuropeptide YLILLY CO ELI·Filed 1994·Granted May 13, 2003·4 cites·3 claims
- 2648US6521611B2Non-peptidyl vasopressin V1a antagonistsLILLY CO ELI·Filed 2000·Granted Feb 18, 2003·0 cites·8 claims
- 2745US4868199ANovel enolamides, pharmaceutical compositions and methods of use thereof for activity as modulators of the arachidonic acid cascadeWARNER LAMBERT CO·Filed 1988·Granted Sep 19, 1989·2 cites·14 claims
- 2845US4868205ANovel enolamides, pharmaceutical compositions and methods of use thereof for activity as modulators of the arachidonic acid cascadeWARNER LAMBERT CO·Filed 1988·Granted Sep 19, 1989·2 cites·9 claims
- 2945US4868195ANovel enolamides, pharmaceutical compositions and methods of use thereof for activity as modulators of the arachidonic acid cascadeWARNER LAMBERT CO·Filed 1988·Granted Sep 19, 1989·2 cites·34 claims
- 3042US5545641AMethods of inhibiting physiological conditions associated with an excess of bradykininLILLY CO ELI·Filed 1994·Granted Aug 13, 1996·4 cites·4 claims
- 3140US2004034102A1Oral pediatric trimethobenzamide formulations and methodsKING PHARMACEUTICALS INC·Filed 2003·Application pending·0 cites
- 3239US4921871AEnolamides, pharmaceutical compositions and methods of use thereof for treating inflammationWARNER LAMBERT CO·Filed 1987·Granted May 1, 1990·1 cites·80 claims
- 3337US4874758ANovel enolamides, pharmaceutical compositions and methods of use thereof for activity as modulators of the arachidonic acid cascadeWARNER LAMBERT CO·Filed 1988·Granted Oct 17, 1989·1 cites·11 claims
- 3431US5514675ANaphthyl bradykinin receptor antagonistsLILLY CO ELI·Filed 1994·Granted May 7, 1996·1 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when Robert F. Bruns, Jr. files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →